Clinical Trials Browser

Completed × Decitabine × 30 days × Clear all

NCT02204085 2026-04-03

A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute